A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans

AIDS Research and Human Retroviruses

Volumn 27, Issue 9, 2011, Pages 973-979

  Butt, Adeel A ^a,b,c   McGinnis, Kathleen ^b   Skanderson, Melissa ^b   Justice, Amy C ^d,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Center for Health Equity Research and Promotion   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DECOMPENSATED LIVER CIRRHOSIS; DEMOGRAPHY; DRUG ABUSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; VETERAN;

ADULT; ANTIVIRAL AGENTS; ELECTRONIC HEALTH RECORDS; ELIGIBILITY DETERMINATION; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; REGISTRIES; VETERANS;

EID: 80052058359     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0004     Document Type: Article

References (30)

1. Zeuzem S, Feinman SV, Rasenack J, et al.: Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 2000; 343:1666-1672.
2. Fried MW, Shiffman ML, Reddy KR, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347(13):975-982.
3. Hadziyannis SJ, Sette H Jr, Morgan TR, et al.: Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140(5):346-355.
4. Butt AA, Justice AC, Skanderson M, Good CB, and Kwoh CK: Rates and predictors of HCV treatment in HCV-HIV coinfected persons. Alim Pharmacol Ther 2006;24:585-591. (Pubitemid 44127839)
5. Butt AA, Wagener M, Shakil AO, and Ahmad J: Reasons for non-treatment of hepatitis C in veterans in care. J Viral He-pat 2005;12:81-85. (Pubitemid 40188778)
6. Butt AA, Justice AC, Skanderson M, et al.: Rate and predictors of treatment prescription for hepatitis C. Gut 2007;56(3):385-389. (Pubitemid 46579770)
7. Hallinan R, Byrne A, Agho K, and Dore GJ: Referral for chronic hepatitis C treatment from a drug dependency treatment setting. Drug Alcohol Depend 2007;88(1):49-53. (Pubitemid 46400306)
8. Irving WL, Smith S, Cater R, et al.: Clinical pathways for patients with newly diagnosed hepatitis C-what actually happens. J Viral Hepat 2006;13(4):264-271.
9. Zinkernagel AS, von W, V, Ledergerber B, et al.: Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: The Swiss HIV cohort study. Antivir Ther 2006;11(2):131-142.
10. Morrill JA, Shrestha M, and Grant RW: Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med 2005;20(8):754-758. (Pubitemid 41141009)
11. Butt AA, McGinnis KA, Skanderson M, and Justice AC: Hepatitis C treatment completion rates in routine clinical care. Liver Int 2009;30:240-250.
12. Muir AJ and Provenzale D: A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol 2002;34(3):268-271. (Pubitemid 34177383)
13. Falck-Ytter YM, Kale HM, Mullen KDM, et al.: Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002;136(4):288-292.
14. Fultz SL, Justice AC, Butt AA, et al.: Testing, referral, and treatment patterns for hepatitis C coinfection in a cohort of veterans with HIV infection. Clin Infect Dis 2003;36:1039-1046. (Pubitemid 36513290)
15. Yee HS, Currie SL, Darling JM, and Wright TL: Management and treatment of hepatitis C viral infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. Am J Gastroenterol 2006;101(10):2360-2378. (Pubitemid 44477566)
16. Butt AA: Hepatitis C virus infection: The new global epidemic. Expert Rev Anti-Infect Ther 2005;3(2):241-249 (Pubitemid 40598003)
17. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002;19(3):1-46.
18. APASL Hepatitis C Working Party: Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol 2007;22(5):615-633.
19. Butt AA, Wang X, Budoff M, et al.: Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009;49(2):225-232.
20. Butt AA, Wang X, and Moore CM: Effect of HCV and its treatment upon survival. Hepatology 2009;50:387-392.
21. Butt AA, Khan UA, McGinnis KA, Skanderson M, and Kwoh CK: Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. J Viral Hepatol 2007;14:890-896. (Pubitemid 350211412)
22. Bozzette SA, Ake CF, Tam HK, Chang SW, and Louis TA: Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Eng J Med 2003;348(8):702-710. (Pubitemid 36237039)
23. Kramer JR, Giordano TP, Souchek J, and El Serag HB: Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol 2005;42(3):309-314. (Pubitemid 40254243)
24. Kramer JR, Giordano TP, Souchek J, et al.: The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 2005;100(1):56-63. (Pubitemid 41623269)
25. Giordano TP, Kramer JR, Souchek J, Richardson P, and El Serag HB: Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: A cohort study, 1992-2001. Arch Intern Med 2004;164(21): 2349-2354. (Pubitemid 39532246)
26. Fultz SL, Skanderson M, Mole LA, et al.: Development and verificationofa"virtual" cohort using the National VAHealth Information System. Med Care 2006;44(8 Suppl 2):S25-S30. (Pubitemid 44284254)
27. Justice AC, Lasky E, McGinnis KA, et al.: Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care 2006;44(8 Suppl 2):S52-S60. (Pubitemid 44284258)
28. Goulet JL, Fultz SL, McGinnis KA, and Justice AC: Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS 2005;19(Suppl 3):S99-S105. (Pubitemid 41682176)
29. McGinnis KA, Skanderson M, Levin F, et al.: Comparison of two VA laboratory data repositories indicates that missing data vary despite originating from the same source. Med Care 2009;47(1):121-124.
30. Armstrong GL, Wasley A, Simard EP, et al.: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144(10):705-714. (Pubitemid 46780630)